Processing Speed Accounts for the Discriminative Power of a Smartphone Go/No-Go Task in Multiple Sclerosis
- 1NIAID/NIH
Abstract
BackgroundIdentifying and longitudinally measuring cognitive decline remains challenging because traditional assessments rely largely on episodic, in-person administration of analog scales by trained examiners. Smartphone technology provides a scalable alternative capable of extracting distinct digital biomarkers from continuous sensor and event streams. Following the integration of several cognitive modules into the self-administered Neurological Functions Test Suite (NeuFun-TS), this study evaluates the clinical utility and incremental validity of a final candidate module: an equiprobable (50/50) continuous vigilance Go/No-Go paradigm.
MethodsWe analyzed 3,270 quality-controlled trials from 303 participants, focusing primary analyses on 488 first-trial observations across 34 healthy donors (HD) and 213 multiple sclerosis (MS) participants. From the raw event stream, we screened 16 candidate metrics and retained 10 based on their intrinsic psychometric properties. Using these 10 metrics, we evaluated diagnostic group separation, test-retest reliability, correlations with clinical and magnetic resonance imaging (MRI) benchmarks, and incremental validity over existing digital modules: the randomized Symbol Digit Modalities Test (rSDMT) and the Motor Sequencing Test (MST), using paired observations.
ResultsAlthough nine of the 10 outcomes significantly separated HD from MS and seven separated relapsing-remitting from progressive MS subtypes (all adjusted p < 0.05), discriminative power was driven almost entirely by response latency rather than commission errors or inhibitory metrics. Multi-predictor composite scores offered no diagnostic advantage over reaction time alone. Furthermore, the Go/No-Go task demonstrated poor-to-moderate longitudinal test-retest reliability and failed to provide incremental clinical value over existing modules.
ConclusionAlthough the smartphone-based Go/No-Go task reflects processing speed impairment in MS, its discriminative capability is redundant with simpler reaction time metrics already implemented in the platform. Consequently, the Go/No-Go module was excluded from NeuFun-TS to minimize patient testing burden without compromising diagnostic sensitivity.
Related
- Pilot Study of Smartphone-Based Neuroperformance Tests in Multiple Sclerosis
- Baclofen for Spasticity in Multiple Sclerosis: A Comprehensive Narrative Review
- A 35-Year-Old Woman With Multiple Sclerosis and a New Atypical Thalamic Lesion: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings.
- Chronic lesion expansion persists in secondary progressive multiple sclerosis and is associated with neurodegeneration
- Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases
BibTeX
@misc{kosa2026processing,
title = {{Processing Speed Accounts for the Discriminative Power of a Smartphone Go/No-Go Task in Multiple Sclerosis}},
author = {P. Kosa and A. Moghadam Ahmadi and M. Kanu and Y. Mejia and E. Mekasha and C. Steltzner and B. Bielekova},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.09.26362640},
url = {https://www.medrxiv.org/content/10.64898/2026.09.09.26362640v1},
note = {CC0},
}
RIS
TY - UNPB
TI - Processing Speed Accounts for the Discriminative Power of a Smartphone Go/No-Go Task in Multiple Sclerosis
AU - P. Kosa
AU - A. Moghadam Ahmadi
AU - M. Kanu
AU - Y. Mejia
AU - E. Mekasha
AU - C. Steltzner
AU - B. Bielekova
PY - 2026
DA - 2026/09/09
PB - medRxiv
DO - 10.64898/2026.09.09.26362640
UR - https://www.medrxiv.org/content/10.64898/2026.09.09.26362640v1
AB - BackgroundIdentifying and longitudinally measuring cognitive decline remains challenging because traditional assessments rely largely on episodic, in-person administration of analog scales by trained examiners. Smartphone technology provides a scalable alternative capable of extracting distinct digital biomarkers from continuous sensor and event streams. Following the integration of several cognitive modules into the self-administered Neurological Functions Test Suite (NeuFun-TS), this study evaluates the clinical utility and incremental validity of a final candidate module: an equiprobable (50/50) continuous vigilance Go/No-Go paradigm. MethodsWe analyzed 3,270 quality-controlled trials from 303 participants, focusing primary analyses on 488 first-trial observations across 34 healthy donors (HD) and 213 multiple sclerosis (MS) participants. From the raw event stream, we screened 16 candidate metrics and retained 10 based on their intrinsic psychometric properties. Using these 10 metrics, we evaluated diagnostic group separation, test-retest reliability, correlations with clinical and magnetic resonance imaging (MRI) benchmarks, and incremental validity over existing digital modules: the randomized Symbol Digit Modalities Test (rSDMT) and the Motor Sequencing Test (MST), using paired observations. ResultsAlthough nine of the 10 outcomes significantly separated HD from MS and seven separated relapsing-remitting from progressive MS subtypes (all adjusted p < 0.05), discriminative power was driven almost entirely by response latency rather than commission errors or inhibitory metrics. Multi-predictor composite scores offered no diagnostic advantage over reaction time alone. Furthermore, the Go/No-Go task demonstrated poor-to-moderate longitudinal test-retest reliability and failed to provide incremental clinical value over existing modules. ConclusionAlthough the smartphone-based Go/No-Go task reflects processing speed impairment in MS, its discriminative capability is redundant with simpler reaction time metrics already implemented in the platform. Consequently, the Go/No-Go module was excluded from NeuFun-TS to minimize patient testing burden without compromising diagnostic sensitivity.
ER -